Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Seib, C; Harbeck, E; Anderson, D; Porter-Steele, J; Nehill, C; Sanmugarajah, J; Perrin, L; Shannon, C; Cabraal, N; Jennings, B; Otton, G; Adams, C; Mellon, A; Chambers, S

Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Seib, C Harbeck, E Anderson, D

Porter-Steele, J Nehill, C Sanmugarajah, J Perrin, L Shannon, C Cabraal, N Jennings, B Otton, G Adams, C Mellon, A Chambers, S

Permalink

Publisher:: WILEY
Publication Type:: Journal Article
Citation:: Psychooncology, 2024, 33, (3), pp. e6328
Issue Date:: 2024-03

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (438.95 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Seib, C
dc.contributor.author	Harbeck, E
dc.contributor.author	Anderson, D https://orcid.org/0000-0001-7416-7522
dc.contributor.author	Porter-Steele, J
dc.contributor.author	Nehill, C
dc.contributor.author	Sanmugarajah, J
dc.contributor.author	Perrin, L
dc.contributor.author	Shannon, C
dc.contributor.author	Cabraal, N
dc.contributor.author	Jennings, B
dc.contributor.author	Otton, G
dc.contributor.author	Adams, C
dc.contributor.author	Mellon, A
dc.contributor.author	Chambers, S https://orcid.org/0000-0003-2369-6111
dc.date.accessioned	2024-09-23T05:16:23Z
dc.date.available	2024-03-07
dc.date.available	2024-09-23T05:16:23Z
dc.date.issued	2024-03
dc.identifier.citation	Psychooncology, 2024, 33, (3), pp. e6328
dc.identifier.issn	1057-9249
dc.identifier.issn	1099-1611
dc.identifier.uri	http://hdl.handle.net/10453/180924
dc.description.abstract	OBJECTIVE: Nuanced distress screening tools can help cancer care services manage specific cancer groups' concerns more efficiently. This study examines the sensitivity and specificity of a tool specifically for women with gynaecological cancers (called the Gynaecological Cancer Distress Screen or DT-Gyn). METHODS: This paper presents cross-sectional data from individuals recently treated for gynaecological cancer recruited through Australian cancer care services, partner organisations, and support/advocacy services. Receiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT-Gyn against criterion measures for anxiety (GAD-7), depression (patient health questionnaire), and distress (IES-R and K10). RESULTS: Overall, 373 individuals aged 19-91 provided complete data for the study. Using the recognised distress thermometer (DT) cut-off of 4, 47% of participants were classified as distressed, while a cut-off of 5 suggested that 40% had clinically relevant distress. The DT-Gyn showed good discriminant ability across all measures (IES-R: area under the curve (AUC) = 0.86, 95% CI = 0.82-0.90; GAD-7: AUC = 0.89, 95% CI = 0.85-0.93; K10: AUC = 0.88, 95% CI = 0.85-0.92; PHQ-9: AUC = 0.85, 95% CI = 0.81-0.89) and the Youden Index suggested an optimum DT cut-point of 5. CONCLUSIONS: This study established the psychometric properties of the DT-Gyn, a tool designed to identify and manage the common sources of distress in women with gynaecological cancers. We suggest a DT cut point ≥5 is optimal in detecting 'clinically relevant' distress, anxiety, and depression in this population.
dc.format	Print
dc.language	eng
dc.publisher	WILEY
dc.relation.ispartof	Psychooncology
dc.relation.isbasedon	10.1002/pon.6328
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1103 Clinical Sciences, 1112 Oncology and Carcinogenesis, 1701 Psychology
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.classification	32 Biomedical and clinical sciences
dc.subject.classification	52 Psychology
dc.subject.mesh	Humans
dc.subject.mesh	Female
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Depression
dc.subject.mesh	Stress, Psychological
dc.subject.mesh	Australia
dc.subject.mesh	Sensitivity and Specificity
dc.subject.mesh	Anxiety
dc.subject.mesh	Neoplasms
dc.subject.mesh	Psychometrics
dc.subject.mesh	Genital Neoplasms, Female
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Mass Screening
dc.subject.mesh	Humans
dc.subject.mesh	Neoplasms
dc.subject.mesh	Genital Neoplasms, Female
dc.subject.mesh	Mass Screening
dc.subject.mesh	Sensitivity and Specificity
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Depression
dc.subject.mesh	Stress, Psychological
dc.subject.mesh	Anxiety
dc.subject.mesh	Psychometrics
dc.subject.mesh	Australia
dc.subject.mesh	Female
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Humans
dc.subject.mesh	Female
dc.subject.mesh	Cross-Sectional Studies
dc.subject.mesh	Depression
dc.subject.mesh	Stress, Psychological
dc.subject.mesh	Australia
dc.subject.mesh	Sensitivity and Specificity
dc.subject.mesh	Anxiety
dc.subject.mesh	Neoplasms
dc.subject.mesh	Psychometrics
dc.subject.mesh	Genital Neoplasms, Female
dc.subject.mesh	Surveys and Questionnaires
dc.subject.mesh	Mass Screening
dc.title	Establishing the sensitivity and specificity of the gynaecological cancer distress screen.
dc.type	Journal Article
utslib.citation.volume	33
utslib.location.activity	England
utslib.for	1103 Clinical Sciences
utslib.for	1112 Oncology and Carcinogenesis
utslib.for	1701 Psychology
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Women & Children’s Health Research Collaborative (WCHC)
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2024-09-23T05:16:21Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	33
utslib.citation.issue	3

Abstract:

OBJECTIVE: Nuanced distress screening tools can help cancer care services manage specific cancer groups' concerns more efficiently. This study examines the sensitivity and specificity of a tool specifically for women with gynaecological cancers (called the Gynaecological Cancer Distress Screen or DT-Gyn). METHODS: This paper presents cross-sectional data from individuals recently treated for gynaecological cancer recruited through Australian cancer care services, partner organisations, and support/advocacy services. Receiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT-Gyn against criterion measures for anxiety (GAD-7), depression (patient health questionnaire), and distress (IES-R and K10). RESULTS: Overall, 373 individuals aged 19-91 provided complete data for the study. Using the recognised distress thermometer (DT) cut-off of 4, 47% of participants were classified as distressed, while a cut-off of 5 suggested that 40% had clinically relevant distress. The DT-Gyn showed good discriminant ability across all measures (IES-R: area under the curve (AUC) = 0.86, 95% CI = 0.82-0.90; GAD-7: AUC = 0.89, 95% CI = 0.85-0.93; K10: AUC = 0.88, 95% CI = 0.85-0.92; PHQ-9: AUC = 0.85, 95% CI = 0.81-0.89) and the Youden Index suggested an optimum DT cut-point of 5. CONCLUSIONS: This study established the psychometric properties of the DT-Gyn, a tool designed to identify and manage the common sources of distress in women with gynaecological cancers. We suggest a DT cut point ≥5 is optimal in detecting 'clinically relevant' distress, anxiety, and depression in this population.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/180924